OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review
OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals products. The company’s product portfolio includes 4K score test used for diagnosis of prostate cancer; Rayaldee (calcifediol), an extended-release capsule for treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease; and the Claros analyzer, a blood performance test. OPKO develops products using proprietary technologies including, Carboxyl Terminal Peptide (CTP) technology, reversible PEGylation technology and AntagoNAT technology. It is advancing pipeline products targeted for the treatment of hypophosphatemia, obesity, diabetes, haemophilia, growth hormone deficiency, dravet syndrome and other diseases. It also offers veterinary products. The company has operational presence with offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.
OPKO Health Inc Key Recent Developments
Apr 28,2021: OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
Mar 03,2021: OPKO Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Feb 22,2021: New York State partners with BioReference Laboratories to spearhead the NY forward COVID-19 rapid test program to help reopen the New York economy
Feb 18,2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
Feb 07,2021: Opko Health's chief accounting officer resigns
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals products. The company’s product portfolio includes 4K score test used for diagnosis of prostate cancer; Rayaldee (calcifediol), an extended-release capsule for treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease; and the Claros analyzer, a blood performance test. OPKO develops products using proprietary technologies including, Carboxyl Terminal Peptide (CTP) technology, reversible PEGylation technology and AntagoNAT technology. It is advancing pipeline products targeted for the treatment of hypophosphatemia, obesity, diabetes, haemophilia, growth hormone deficiency, dravet syndrome and other diseases. It also offers veterinary products. The company has operational presence with offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.
OPKO Health Inc Key Recent Developments
Apr 28,2021: OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
Mar 03,2021: OPKO Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Feb 22,2021: New York State partners with BioReference Laboratories to spearhead the NY forward COVID-19 rapid test program to help reopen the New York economy
Feb 18,2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
Feb 07,2021: Opko Health's chief accounting officer resigns
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
OPKO Health Inc - Key Facts
OPKO Health Inc - Key Employees
OPKO Health Inc - Key Employee Biographies
OPKO Health Inc - Major Products and Services
OPKO Health Inc - History
OPKO Health Inc - Company Statement
OPKO Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
OPKO Health Inc - Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Geographical Segment: Chile
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Mexico
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The US
Performance
R&D Overview
OPKO Health Inc - Corporate Strategy
OPKO Health Inc - SWOT Analysis
SWOT Analysis - Overview
OPKO Health Inc - Strengths
OPKO Health Inc - Weaknesses
OPKO Health Inc - Opportunities
OPKO Health Inc - Threats
OPKO Health Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OPKO Health Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 28, 2021: OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
Mar 03, 2021: OPKO Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Feb 22, 2021: New York State partners with BioReference Laboratories to spearhead the NY forward COVID-19 rapid test program to help reopen the New York economy
Feb 18, 2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
Feb 07, 2021: Opko Health's chief accounting officer resigns
Jan 26, 2021: OPKO Health’s GeneDx adds repeat expansion analysis genetic tests for diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and other common forms of Hereditary Ataxia
Jan 13, 2021: OPKO Health's BioReference Laboratories introduces Scarlet Health, an in-home diagnostic service to expand digital health access
Dec 31, 2020: Buffalo Bills and OPKO Health's BioReference Laboratories initiate the first large scale, mandatory COVID-19 fan Testing Program
Dec 21, 2020: OPKO Health appoints Dr. Roger Medel to its Board of Directors
Oct 29, 2020: OPKO Health reports 2020 third quarter business highlights and financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
OPKO Health Inc - Key Facts
OPKO Health Inc - Key Employees
OPKO Health Inc - Key Employee Biographies
OPKO Health Inc - Major Products and Services
OPKO Health Inc - History
OPKO Health Inc - Company Statement
OPKO Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
OPKO Health Inc - Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Geographical Segment: Chile
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Mexico
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The US
Performance
R&D Overview
OPKO Health Inc - Corporate Strategy
OPKO Health Inc - SWOT Analysis
SWOT Analysis - Overview
OPKO Health Inc - Strengths
OPKO Health Inc - Weaknesses
OPKO Health Inc - Opportunities
OPKO Health Inc - Threats
OPKO Health Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OPKO Health Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 28, 2021: OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
Mar 03, 2021: OPKO Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Feb 22, 2021: New York State partners with BioReference Laboratories to spearhead the NY forward COVID-19 rapid test program to help reopen the New York economy
Feb 18, 2021: OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
Feb 07, 2021: Opko Health's chief accounting officer resigns
Jan 26, 2021: OPKO Health’s GeneDx adds repeat expansion analysis genetic tests for diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and other common forms of Hereditary Ataxia
Jan 13, 2021: OPKO Health's BioReference Laboratories introduces Scarlet Health, an in-home diagnostic service to expand digital health access
Dec 31, 2020: Buffalo Bills and OPKO Health's BioReference Laboratories initiate the first large scale, mandatory COVID-19 fan Testing Program
Dec 21, 2020: OPKO Health appoints Dr. Roger Medel to its Board of Directors
Oct 29, 2020: OPKO Health reports 2020 third quarter business highlights and financial results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
OPKO Health Inc, Key Facts
OPKO Health Inc, Key Employees
OPKO Health Inc, Key Employee Biographies
OPKO Health Inc, Major Products and Services
OPKO Health Inc, History
OPKO Health Inc, Other Locations
OPKO Health Inc, Subsidiaries
OPKO Health Inc, Key Competitors
OPKO Health Inc, Ratios based on current share price
OPKO Health Inc, Annual Ratios
OPKO Health Inc, Annual Ratios (Cont...1)
OPKO Health Inc, Interim Ratios
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OPKO Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
OPKO Health Inc, Key Facts
OPKO Health Inc, Key Employees
OPKO Health Inc, Key Employee Biographies
OPKO Health Inc, Major Products and Services
OPKO Health Inc, History
OPKO Health Inc, Other Locations
OPKO Health Inc, Subsidiaries
OPKO Health Inc, Key Competitors
OPKO Health Inc, Ratios based on current share price
OPKO Health Inc, Annual Ratios
OPKO Health Inc, Annual Ratios (Cont...1)
OPKO Health Inc, Interim Ratios
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
OPKO Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
OPKO Health Inc, Performance Chart (2016 - 2020)
OPKO Health Inc, Ratio Charts
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021
OPKO Health Inc, Performance Chart (2016 - 2020)
OPKO Health Inc, Ratio Charts
OPKO Health Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
OPKO Health Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021